ALZAMEND NEURO, INC. Debt Conversion, Converted Instrument, Warrants or Options Issued
ALZAMEND NEURO, INC. (ALZN) reported Debt Conversion, Converted Instrument, Warrants or Options Issued of 1.00 million shares for the 0-month period ending 2025-03-03, per its 10-Q filed 2025-03-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 · last filed 2025-03-10
- 2025-03-03: Debt Conversion, Converted Instrument, Warrants or Options Issued 0 month 1.00M shares.
| Period end | Debt Conversion, Converted Instrument, Warrants or Options Issued 0 month |
|---|---|
| 2025-03-03 | 1.00M shares 10-Q · filed 2025-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B |